MedPath

NEUROENABLING TECHNOLOGIES, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Transcutaneous Electrical Spinal Cord Stimulation for Lower Limbs

Not Applicable
Completed
Conditions
Spinal Cord Injury
First Posted Date
2013-09-24
Last Posted Date
2017-01-24
Lead Sponsor
NeuroEnabling Technologies, Inc.
Target Recruit Count
10
Registration Number
NCT01949285
Locations
🇺🇸

University of California Los Angeles, Los Angeles, California, United States

Restoring Arm and Hand Function With Non-invasive Spinal Stimulation

Not Applicable
Completed
Conditions
Paralysis
Spinal Cord Injury
First Posted Date
2013-07-24
Last Posted Date
2017-01-24
Lead Sponsor
NeuroEnabling Technologies, Inc.
Target Recruit Count
7
Registration Number
NCT01906424
Locations
🇺🇸

University of California Los Angeles, Los Angeles, California, United States

🇺🇸

Strides SCI Functional Fitness, San Juan Capistrano, California, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath